RAINBOW PHARMACY LIMITED

Company Registration Number:
07442520 (England and Wales)

Unaudited abridged accounts for the year ended 30 November 2021

Period of accounts

Start date: 01 December 2020

End date: 30 November 2021

RAINBOW PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 30 November 2021

Balance sheet
Notes

RAINBOW PHARMACY LIMITED

Balance sheet

As at 30 November 2021


Notes

2021

2020


£

£
Called up share capital not paid: 0 0
Fixed assets
Tangible assets: 3 44,374 50,964
Total fixed assets: 44,374 50,964
Current assets
Stocks: 80,086 81,774
Debtors: 4 329,409 233,649
Cash at bank and in hand: 610,076 92,653
Total current assets: 1,019,571 408,076
Creditors: amounts falling due within one year: 5 (432,916) (339,175)
Net current assets (liabilities): 586,655 68,901
Total assets less current liabilities: 631,029 119,865
Total net assets (liabilities): 631,029 119,865
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 631,027 119,863
Shareholders funds: 631,029 119,865

The notes form part of these financial statements

RAINBOW PHARMACY LIMITED

Balance sheet statements

For the year ending 30 November 2021 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 27 August 2022
and signed on behalf of the board by:

Name: Ash Tosar
Status: Director

The notes form part of these financial statements

RAINBOW PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2021

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

RAINBOW PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2021

2. Employees

2021 2020
Average number of employees during the period 25 15

RAINBOW PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2021

3. Tangible Assets

Total
Cost £
At 01 December 2020 140,898
Additions 2,425
At 30 November 2021 143,323
Depreciation
At 01 December 2020 89,934
Charge for year 9,015
At 30 November 2021 98,949
Net book value
At 30 November 2021 44,374
At 30 November 2020 50,964

RAINBOW PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2021

4. Debtors

2021 2020
££
Debtors due after more than one year: 0 0

RAINBOW PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2021

5. Creditors: amounts falling due within one year note

Bank loanTrade creditorsCorporation taxDirectors current accountAccrualsOther creditors